TCON - TRACON Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart

TCON is currently covered by 1 analysts with an average potential upside of $32.98 (294.89%) backed by displayed 0 price targets and 1 ratings.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 16.67% with an average time for these price targets to be met of 9 days.

Most recent stock forecast was given by JOEL BEATTY from BAIRD on 15-Aug-2023. First documented stock forecast 02-Mar-2015.

Best performing analysts who are covering TCON - TRACON Pharmaceuticals:

Jim Birchenough Joel Beatty Ling Wang

Currently, out of the existing stock ratings of TCON - 1 which are a Hold (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

3

$2.84 (1775.00%)

7

3 months 15 days ago

0/3 (0%)

$5.61 (768.11%)

Hold

11

$9.6 (685.71%)

10

2 years 8 months 28 days ago

1/2 (50%)

$2.6 (34.37%)

27

Buy

150

$149.84 (93650.00%)

260

7 years 3 months 11 days ago

0/3 (0%)

$90.73 (82.18%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is TCON (TRACON Pharmaceuticals) average time for price targets to be met?

On average it took 9 days on average for the stock forecasts to be realized with a an average price target met ratio 16.67

Which analyst has the current highest performing score on TCON (TRACON Pharmaceuticals) with a proven track record?

JIM BIRCHENOUGH

Which analyst has the current lower performing score on TCON (TRACON Pharmaceuticals) with a proven track record?

LING WANG

Which analyst has the most public recommendations on TCON (TRACON Pharmaceuticals)?

Jim Birchenough works at WELLS FARGO and has 6 price targets and 4 ratings on TCON

Which analyst is the currently most bullish on TCON (TRACON Pharmaceuticals)?

Ling Wang with highest potential upside - $149.84

Which analyst is the currently most reserved on TCON (TRACON Pharmaceuticals)?

Joel Beatty with lowest potential downside - $2.84

To continue looking at which analysts cover the stock please register to the basic or advanced membership

How to use the chart